| 000 | 01842 a2200613 4500 | ||
|---|---|---|---|
| 005 | 20250513104313.0 | ||
| 264 | 0 | _c19961226 | |
| 008 | 199612s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm960365n _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOhnmacht, C J | |
| 245 | 0 | 0 |
_aN-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: KATP potassium channel openers. Modifications on the western region. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cNov 1996 |
||
| 300 |
_a4592-601 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAmides _xchemistry |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMuscle Contraction |
| 650 | 0 | 4 |
_aMuscle, Smooth _xdrug effects |
| 650 | 0 | 4 |
_aPotassium Channels _xagonists |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aUrinary Bladder _xdrug effects |
| 650 | 0 | 4 |
_aUrinary Incontinence _xdrug therapy |
| 700 | 1 | _aRussell, K | |
| 700 | 1 | _aEmpfield, J R | |
| 700 | 1 | _aFrank, C A | |
| 700 | 1 | _aGibson, K H | |
| 700 | 1 | _aMayhugh, D R | |
| 700 | 1 | _aMcLaren, F M | |
| 700 | 1 | _aShapiro, H S | |
| 700 | 1 | _aBrown, F J | |
| 700 | 1 | _aTrainor, D A | |
| 700 | 1 | _aCeccarelli, C | |
| 700 | 1 | _aLin, M M | |
| 700 | 1 | _aMasek, B B | |
| 700 | 1 | _aForst, J M | |
| 700 | 1 | _aHarris, R J | |
| 700 | 1 | _aHulsizer, J M | |
| 700 | 1 | _aLewis, J J | |
| 700 | 1 | _aSilverman, S M | |
| 700 | 1 | _aSmith, R W | |
| 700 | 1 | _aWarwick, P J | |
| 700 | 1 | _aKau, S T | |
| 700 | 1 | _aChun, A L | |
| 700 | 1 | _aGrant, T L | |
| 700 | 1 | _aHowe, B B | |
| 700 | 1 | _aNeilson, K L | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 39 _gno. 23 _gp. 4592-601 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm960365n _zAvailable from publisher's website |
| 999 |
_c8910112 _d8910112 |
||